Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

CHU de Liege

Belgium Domaine Universitaire du Sart-Tilman B35, 4000 Liege, Belgium

  • 3 trials recruiting
  • Glioblastoma · Cerebral haemorrhage · Ovarian cancer
  • Adults and children

About Specializations

CHU de Liege in Liege, Belgium specialises in clinical trials of conditions such as Glioblastoma, Cerebral haemorrhage, Ovarian cancer, Ovarian cancer recurrent, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative therapies for platinum-sensitive recurrent ovarian cancer. The center's work in this area is pivotal in enhancing treatment options and improving patient outcomes.

  • Platinum-sensitive recurrent ovarian cancer
  • Maintenance therapies
  • Combination treatments

By exploring the efficacy of novel maintenance therapies, the center contributes significantly to the advancement of personalized cancer treatment strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Domaine Universitaire du Sart-Tilman B354000 LiegeBelgium
Open in maps ↗
Recruiting now
3 trials
Conditions studied
4

More sites in LiegeBelgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Glioblastoma

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Lomustine
  • Sponsor:Telix Pharmaceuticals (Innovations) Pty Limited

Cerebral haemorrhage

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:University Of Edinburgh

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht

Ovarian cancer+1

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mps-102
  • Sponsor:Arcagy Gineco
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.